Synthesized news with full source attribution.
A fugitive who was discovered to have worked under an alias in the biotech industry has raised questions about how companies hired him despite his criminal history.
Digital Health / MedTech / BioTechChallenges in the electrophysiology and Watchman businesses led Boston Scientific to cut its sales and earnings per share forecasts for the second quarter in a row.
Digital Health / MedTech / BioTechReplimune shares plummeted 40% on concerns FDA scientists are still skeptical of its melanoma drug.
Digital Health / MedTech / BioTechRonald Fischer, a fugitive who evaded scrutiny for two decades, was caught using an alias in the biotech industry, according to STAT.
With the growing demand for AI solutions, entrepreneurs are now looking to monetize their skills in the burgeoning AI market, according to a recent article by Y Combinator.
Challenges in the electrophysiology and Watchman businesses led Boston Scientific to cut its sales and earnings per share forecasts for the second quarter in a row.
Replimune shares plummeted 40% on concerns FDA scientists are still skeptical of its melanoma drug.
The hospital operator expects to lose $10 million more than expected as a result of rising uninsured volumes in Q2.
A growing number of management scholars are using computational linguistics to analyze vast corpora of organizational language, as reported by researchers in a recent study published on July 24, 2026.
Financial Times 50Health tech investors say the founders who win them over aren't the ones with all the answers, but the ones who know exactly what they don't know — and build a team to cover the gap.
Computational linguistics is increasingly being used in management research to analyze vast corpora of organizational language.
A group of tech investors is engaging in a heated debate over the ethics of using copium as an investment strategy, with some calling it a 'get rich quick' scheme and others arguing it's a legitimate way to profit from volatility.
Techbusiness